Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Pam Rosovsky, M.D.

Co-Author

This page shows the publications co-authored by Rachel Rosovsky and Hanny Al-Samkari.
Connection Strength

2.699
  1. Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19). Am J Hematol. 2020 12; 95(12):1479-1485.
    View in: PubMed
    Score: 0.892
  2. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 07 23; 136(4):489-500.
    View in: PubMed
    Score: 0.885
  3. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 05; 174(5):622-632.
    View in: PubMed
    Score: 0.229
  4. A comprehensive evaluation of apixaban in the treatment of venous thromboembolism. Expert Rev Hematol. 2020 02; 13(2):155-173.
    View in: PubMed
    Score: 0.214
  5. A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. Blood Adv. 2020 01 14; 4(1):9-18.
    View in: PubMed
    Score: 0.213
  6. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients. Vasc Health Risk Manag. 2019; 15:175-186.
    View in: PubMed
    Score: 0.205
  7. Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations. JAMA Netw Open. 2021 08 02; 4(8):e2119812.
    View in: PubMed
    Score: 0.059
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.